Effect of Lactobacillus Casei DG (Enterolactis Plus®) in Patient With Irritable Bowel Syndrome: a Pilot Study

NCT02371499 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Irritable Bowel Syndrome

Interventions

DIETARY_SUPPLEMENT: Lactobacillus casei DG
DIETARY_SUPPLEMENT: Placebo

Sponsor

SOFAR S.p.A.